Company Quick10K Filing
Immune Therapeutics
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-05-13 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
8-K 2020-05-14 Other Events
8-K 2020-04-29 Officers, Exhibits
8-K 2020-03-20 Regulation FD, Other Events, Exhibits
8-K 2020-02-27 Enter Agreement, Regulation FD, Other Events, Exhibits
8-K 2020-02-14 Officers, Exhibits
8-K 2019-10-25 Shareholder Vote
8-K 2019-09-20 Enter Agreement, Officers, Exhibits
8-K 2019-05-30 Shareholder Vote
8-K 2019-05-15 Other Events, Exhibits
8-K 2019-01-02 Officers
8-K 2018-06-04 Enter Agreement, M&A, Other Events, Exhibits
8-K 2018-04-26 Other Events, Exhibits
8-K 2018-04-17 Enter Agreement, Leave Agreement
8-K 2018-03-26 Other Events, Exhibits

Immune Therapeutics Financials

IMUN Metrics, Comps, Filings

Quarterly | Annual

Business

Immune Therapeutics, Inc. (the “Company”) was initially incorporated in Florida on December 2, 1993 as Resort Clubs International, Inc. (“Resort Clubs”). It was formed to manage and market golf course properties in resort markets throughout the United States. Galliano International Ltd. (“Galliano”) was incorporated in Delaware on May 27, 1998 and began trading in November 1999 through the filing of a 15C-211. On November 10, 2004, Galliano merged with Resort Clubs. Resort Clubs was the surviving corporation. On August 23, 2010, Resort Clubs changed its name to pH Environmental Inc. (“pH Environmental”).

On April 23, 2012, pH Environmental completed a name change to TNI BioTech, Inc., and on April 24, 2012, we executed a share exchange agreement for the acquisition of all of the outstanding shares of TNI BioTech IP, Inc. On September 4, 2014, a majority of our shareholders approved an amendment to our Amended and Restated Articles of Incorporation, as amended, to change our name to Immune Therapeutics, Inc. We filed our name change amendment with the Secretary of State of Florida on October 27, 2014 changing our name to Immune Therapeutics, Inc.

The Company currently operates out of Orlando, Florida. In July 2012, the Company's focus turned to acquiring patents that would protect and advance the development of new uses of opioid-related immune- therapies, such as low dose naltrexone (“LDN”) and Methionine [Met5]-enkephalin (“MENK”). The Company's therapies are believed to stimulate and/or regulate the immune system in such a way that they provide the potential to treat a variety of diseases. We believe our therapies may be able to correct abnormalities or deficiencies in the immune system in diseases such as HIV infection, autoimmune disease, immune disorders, or cancer; all of which can lead to disease progression and life-threatening situations when the immune system is not functioning optimally.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
OWC Pharmaceutical Research (OWCP) 0 0% -0.2 362% 1,773 1,467 100 0 6,420 6,420 -1,465
Headhunter Group (HHR)
United States Short Oil Fund (DNO) 0 -0% 0.0 0 0 -600 0 -1,856 -1,856 -0
Immune Therapeutics (IMUN) 0 0.0 -29,381% 8 13,479 0 0 -2,476 -2,475 -6
Juniper Industrial (JIH)
PositiveID Corp (PSID)
Live Current Media (LIVC) 0 2.8 -26% 418 108 0 0 -110 -109 -306
Sun Pacific Holding (SNPW) 0 30% -17.5 -20% 6,669 10,975 260 77 -1,301 -315 5,510
Digatrade Financial (DIGAF) 0 0% 527 778 0 0 0 0 0
Lingerie Fighting Championships (BOTY) 0 -49% 0.2 -8,950,200% 23 -11 90 -10 -2
New Century Resources (NCRE) 0 0.0 0 205 0 0 -18 -17 -0
Arete Industries (ARET)
Renewable Energy Acquisition (REAC) 0 0.0 2,353,600% 0 0 -24 -22 -0
Sundial Growers (SNDL)
Energy Transfer Operating (ETP) 0 27% 5.8 4% 95,247,000 59,636,000 40,493,000 10,886,000 3,786,000 8,016,000 46,523,000
Blue Line Protection Group (BLPG) 0 40% 0.0 -189% 1,661 5,917 3,017 1,201 -3,138 -2,534 -19
ABCO Energy (ABCE) 0 38% 0.1 -173% 411 1,359 1,627 622 -713 -502 -28
Guided Therapeutics (GTHP) 0 332% 0.1 1,462% 404 16,413 28 93 5,908 6,835 439
Endonovo Therapeutics (ENDV) 0 73% -0.8 -301% 3,414 19,980 204 150 -10,268 -9,617 7,448
Dominovas Energy (DNRG)

Balance Sheet ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash176231208407234595919231221542313364227498452315300666216
Accounts Receivable28131620300
Inventory214178159159159838300
PP&E2356565443221102233344313131313
Assets21,02120,26019,54019,19218,11917,31716,6126,0555,7475,5965,63141155792376100482401961931641689291248
Accounts Payable3624386308401,0121,6481,8032,0771,8851,9181,9241,9251,8601,5181,5171,8191,6661,7952,2232,3202,4121,6891,5332,0652,0222,1482,275
Long-Term Debt3271,0141,4571,8382,7942,8383,457000
Liabilities2,0072,3352,5242,5613,3374,0502,7273,7034,0444,3754,6955,9996,3407,0067,4889,20110,3897,9068,59411,29911,3529,77110,88711,34211,84612,55313,479
Stockholders' Equity19,01517,92517,01616,63114,78213,26813,8841,746973877758-5,929-4,041-4,672-5,203-5,134-6,162-3,599-3,878-6,495-6,429-9,607-10,719-11,251-11,755-13,471
Income Statement ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000026543000000065650000
Cost of Revenue3300000
Gross Profit3200000
R&D3808,7126,4186,5144,1712,026401941177414111274-196724714911913410937129760000
SG&A1,67719,23412,60837,64212,6133,7269028084024448651,0459398941,0311,0226665566219896381,137588487497389
Tax000000
Net Income-14,690-24,678-19,946-46,746-17,665-4,307-11,202-14,484-2,905-2,591-4,025-7,450-6,645-4,039-3,944-5,191-2,7061,387-1,600-3,777-732-4,348-2,602-709-825-941
Cash Flow ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-05-132015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,183-1,545-1,728-2,115-1,360-1,201-528-754-757-508-639-929-598-802-934-506-529-702-384-438-456-414-55-016-15
Cash Investing-162-2-1-10-43-574100000-20-200-2-120000
Cash Financing1,2081,6021,7062,3151,1871,06858684659650077079870773489256055365036243047339660000